Singapore markets open in 5 hours 56 minutes


NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.670.00 (0.00%)
As of 05:00PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 355.58M
Enterprise value -308.12M
Trailing P/E 1.19
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.50
Price/book (mrq)0.48
Enterprise value/revenue -0.01
Enterprise value/EBITDA -0.02

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-31.93%
S&P500 52-week change 3-16.62%
52-week high 39.75
52-week low 35.01
50-day moving average 35.67
200-day moving average 36.12

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 562.71M
Implied shares outstanding 6N/A
Float 825.84M
% held by insiders 17.76%
% held by institutions 147.95%
Shares short (14 Sept 2022) 41.15M
Short ratio (14 Sept 2022) 4N/A
Short % of float (14 Sept 2022) 4N/A
Short % of shares outstanding (14 Sept 2022) 41.84%
Shares short (prior month 14 Aug 2022) 41.66M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 421.16%
Trailing annual dividend rate 323.51
Trailing annual dividend yield 3414.64%
5-year average dividend yield 4N/A
Payout ratio 430.00%
Dividend date 313 Dec 2021
Ex-dividend date 402 Dec 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in RUB.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 39.35%
Operating margin (ttm)35.64%

Management effectiveness

Return on assets (ttm)12.70%
Return on equity (ttm)43.43%

Income statement

Revenue (ttm)44.82B
Revenue per share (ttm)717.26
Quarterly revenue growth (yoy)29.60%
Gross profit (ttm)16.72B
Net income avi to common (ttm)17.64B
Diluted EPS (ttm)4.75
Quarterly earnings growth (yoy)0.30%

Balance sheet

Total cash (mrq)54.04B
Total cash per share (mrq)861.74
Total debt (mrq)6.73B
Total debt/equity (mrq)13.69
Current ratio (mrq)2.34
Book value per share (mrq)777.77

Cash flow statement

Operating cash flow (ttm)10.17B
Levered free cash flow (ttm)8.5B